HL-Histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs

INIS

• adrenergics 11%
• affinity 50%
• drugs 61%
• gain 44%
• histamine 27%
• hydrogen 1 33%
• hyperglycemia 5%
• hypertension 5%
• interactions 5%
• principal component analysis 5%
• receptors 100%
• serotonin 5%
• side effects 5%
• therapy 5%
• weight 44%

Pharmacology, Toxicology and Pharmaceutical Science

• Adrenergic Receptor 5%
• Atypical Antipsychotics 11%
• Complication 5%
• Diabetic Ketoacidosis 5%
• Diseases 5%
• Drug 27%
• Histamine H1 Receptor 16%
• Histamine H1 Receptor Antagonist 5%
• Histamine Receptor 5%
• Hyperglycemia 5%
• Hyperlipidemia 5%
• Hypertension 5%
• Neurotransmitter Receptor 5%
• Pharmaceutical Therapy 5%
• Receptor 50%
• Schizophrenia 5%
• Serotonin 2C Receptor 5%
• Side Effect 5%

Neuroscience

• 5-HT2C Receptor 5%
• 5-HT6 Receptor 11%
• 5-HT7 Receptor 5%
• Antipsychotic 22%
• Atypical Antipsychotic 11%
• Dementia Praecox 5%
• Discriminant Function Analysis 11%
• Eicosanoid Receptor 22%
• Histamine 5%
• Histamine H1 Receptor 11%
• Histamine Receptor 11%
• Hyperglycemia 5%
• Hypertension 5%
• Muscarinic M3 Receptor 5%
• Neurotransmitter Receptor 5%
• Receptor Affinity 22%
• Receptor Antagonist 5%